Blood Cancer Clinical Trials
46 clinical trials for Blood Cancer across international registries, including 15 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies — RECRUITING · PHASE1
- Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies — RECRUITING · PHASE1
- Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE) — RECRUITING · NA
- Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue — RECRUITING · PHASE2
- A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties — RECRUITING · NA
- Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy — RECRUITING · NA
- Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial — RECRUITING · PHASE2
- A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax — RECRUITING · PHASE1
- Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut — RECRUITING
- Immune Profiling for Cancer Immunotherapy Response — RECRUITING
- Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years — RECRUITING · NA
- IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers — RECRUITING · PHASE1
- Better Leukemia Diagnostics Through AI (BELUGA) — RECRUITING
- European Rare Blood Disorders Platform (ENROL) — RECRUITING
- The Leukemia and Lymphoma Society (LLS) National Research Registry — RECRUITING
- A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients — COMPLETED · NA
- Rutgers University Study of the Genetics of Blood Cancers — NOT_YET_RECRUITING
- EWALL-PH-03: An open label, 2-arm, Randomised phase II study to Compare the Safety and Efficacy of Ponatinib plus Chemotherapy with Imatinib plus Chemotherapy as front-line therapy for patients aged 55 years and over with Philadelphia chromosome positive (Ph+ or BCR-ABL+) Acute Lymphoblastic Leukemia (ALL) — TERMINATED · PHASE2
- Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation — ACTIVE_NOT_RECRUITING · PHASE2
- Resiliency in Older Adults Undergoing Bone Marrow Transplant — COMPLETED
- Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy. — COMPLETED
- Enhanced Assistance During Radiotherapy for Unmet Essential Needs — COMPLETED · NA
- Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention — COMPLETED
- Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant. — ACTIVE_NOT_RECRUITING · NA
- Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer — NOT_YET_RECRUITING · NA
- MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies — WITHDRAWN · NA
- Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation — COMPLETED
- Clinical Evaluation of the Scopio Cell Morphology Technology — NOT_YET_RECRUITING
- Early Integration of Palliative and Supportive Care in Cellular Therapy — OTHER · NA
- A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms — WITHDRAWN · PHASE1
- Positive Psychology Intervention In HSCT — COMPLETED · NA
- Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201) — OTHER
- Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study — OTHER
- Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients — OTHER
- Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL — TERMINATED · PHASE1
- Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy — WITHDRAWN · NA
- Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies — COMPLETED · PHASE2
- A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer — COMPLETED · PHASE1
- Rehabilitation Needs of the Malaysian Haematological Cancer Survivors — COMPLETED
- Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors — COMPLETED · NA
- Allogeneic Transplantation From Related Haploidentical Donors — COMPLETED · PHASE2
- Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma — COMPLETED · PHASE2
- A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies — COMPLETED · PHASE1
- TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD — COMPLETED · PHASE2
- Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors — COMPLETED · PHASE2
- A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS) — COMPLETED · PHASE1
Refine this search